Skip to content

Umbrella Study for Single Patient Treatments in Oncology

Advanced Cancer | Rare Diseases

The purpose of this study is to collect data on how advanced and rare cancers respond to biomarker-based treatments.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria \& Exclusion Criteria:

Patient's existing genomic information from tumor molecular profiling will be discussed in the hospital expert molecular tumor board rounds consisting of representatives from specialist genomic profiling and medical oncology departments to decide N of 1 treatment for the patient. The discussion will surround the best next therapeutic option in the patient's cancer subtype with or without clear standard of care guidelines. Therefore, specific eligibility criteria aside from individual patient's medical history is not applicable.

Study Location

University Health Network, Princess Margaret Cancer Centre
University Health Network, Princess Margaret Cancer Centre
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Amit Oza, Dr.

[email protected]
416 946 4450
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT06285500